Suche | Myliveroom — Live Events & Online Communities

Rohit More hat ein neuen Blog hinzugefügt Andere
2026-06-17 05:24:55 - Übersetzen -

Adalimumab Biosimilar Market Accelerates as Cost-Effective Biologic Therapies Expand Access to Autoimmune Disease Treatment
According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. For generating the Adalimumab Biosimilar...

0 Kommentare 0 Geteilt 24 Ansichten 0 Bewertungen

Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
Anand Dasre hat ein neuen Blog hinzugefügt Andere
2026-05-15 12:47:52 - Übersetzen -

Hydroxychloroquine Market Size, Share and Growth Analysis 2025–2033
The global Hydroxychloroquine Market is witnessing steady growth due to the increasing prevalence of autoimmune diseases, malaria treatment demand, and expanding pharmaceutical production capacities. Hydroxychloroquine is widely used for the treatment of rheumatoid arthritis, systemic lupus erythematosus, and malaria because of its anti-inflammatory and immunomodulatory properties. Rising...

0 Kommentare 0 Geteilt 637 Ansichten 0 Bewertungen

Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
Ksh Dbmr hat ein neuen Blog hinzugefügt Andere
2025-08-14 07:11:44 - Übersetzen -

Lupus Therapeutic Market Trends, Opportunities, and Growth Forecast
Executive Summary Lupus Therapeutic Market Opportunities by Size and Share CAGR Value Global lupus therapeutic market size was valued at USD 3.32 billion in 2024 and is projected to reach USD 6.67 billion by 2032, with a CAGR of 9.10% during the forecast period of 2025 to 2032. An international Lupus Therapeutic Market report lends a hand to identify how the market is going to...

0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen

Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!